Related Experiment Videos
Resistance to activated protein C in systemic lupus erythematosus patients with antiphospholipid antibodies
European Journal of Haematology
|September 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
Genetic contribution of the CD14 -159C/T dimorphism in the promoter region in Japanese RA.
Clinical and experimental rheumatology·2008
Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by regulating the PAI-1 gene expression.
Journal of thrombosis and haemostasis : JTH·2006
CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression.
Journal of thrombosis and haemostasis : JTH·2006
Endoscope disinfection using chlorine dioxide in an automated washer-disinfector.
The Journal of hospital infection·2006
BCMA-Targeted Immunotherapy in Early Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Practical Management.
European journal of haematology·2026
Beyond Extranodal Site Count: Clinical and Anatomical Characterization of Primary Multifocal Extranodal Diffuse Large B-Cell Lymphoma.
European journal of haematology·2026
Patient and Healthcare Provider Satisfaction With Subcutaneous Versus Intravenous Administration of Daratumumab in Combination With Lenalidomide and Dexamethasone as First-Line Treatment in Patients With Newly Diagnosed Non-Transplant Eligible Multiple Myeloma: Final Results of the MYLENE Study.
European journal of haematology·2026
BCMA Targeted Therapies and Their Impact on Outcomes in Relapsed or Refractory Multiple Myeloma: Results From the French EMMY Cohort.
European journal of haematology·2026
Castleman Disease: Unraveling Diagnostic Challenges Through Clinical and Pathologic Perspectives.
European journal of haematology·2026
Case Report: Efgartigimod in refractory non-tumor Lambert-Eaton myasthenic syndrome.
Frontiers in immunology·2026
Case Report: IgG4-related lung disease.
Frontiers in immunology·2026